Urbanek Christian, Jung Jasmin, Güney Resul, Potreck Arne, Nagel Simon, Grau Armin J, Boujan Timan, Luckscheiter Andre, Bendszus Martin, Möhlenbruch Markus A, Seker Fatih
Department of Neurology, Clinical Centre of the City of Ludwigshafen, Ludwigshafen, Germany.
Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Front Neurol. 2023 Mar 9;14:1142983. doi: 10.3389/fneur.2023.1142983. eCollection 2023.
This study aimed at comparing clinical outcome, recanalization success and time metrics in the "drip and ship" (DS) vs. "drive the doctor" (DD) concept in a comparable setting.
This is a retrospective analysis of thrombectomy registries of a comprehensive stroke center (CSC) and a thrombectomy-capable stroke center (TSC). Patients, who were transferred from the TSC to the CSC, were classified as DS. Patients treated at the TSC by an interventionalist transferred from the CSC were classified as DD. Good outcome was defined as mRS 0-2 or equivalent to premorbid mRS at discharge. Recanalization (TICI 2b-3 or equivalent) and time metrics were compared in both groups.
In total, 295 patients were included, of which 116 (39.3%) were treated in the DS concept and 179 (60.7%) in the DD concept. Good clinical outcome was similarly achieved in DS and DD (DS 25.0% vs. DD 31.3%, = 0.293). mRS on discharge (DS median 4, DD median 4, = 0.686), NIHSS improvement (DS median 4, DD median 5, = 0.582) and NIHSS on discharge (DS median 9, DD median 7, = 0.231) were similar in both groups. Successful reperfusion was achieved similarly in DS (75.9%) and DD as well (81.0%, = 0.375). Time from onset to reperfusion (median DS 379 vs. DD 286 min, = 0.076) and time from initial imaging to reperfusion were longer in DS compared to DD (median DS 246 vs. DD 162 min, < 0.001).
The DD concept is time saving while achieving similar clinical outcome and recanalization results.
本研究旨在比较在可比环境下“点滴转运”(DS)与“医生转运”(DD)概念在临床结局、再通成功率和时间指标方面的差异。
这是一项对综合卒中中心(CSC)和具备血栓切除术能力的卒中中心(TSC)的血栓切除术登记数据进行的回顾性分析。从TSC转至CSC的患者被归类为DS组。由从CSC转来的介入医生在TSC进行治疗的患者被归类为DD组。良好结局定义为出院时改良Rankin量表(mRS)评分为0 - 2分或与病前mRS评分相当。比较两组的再通情况(脑梗死溶栓分级(TICI)2b - 3级或相当情况)和时间指标。
总共纳入295例患者,其中116例(39.3%)采用DS概念治疗,179例(60.7%)采用DD概念治疗。DS组和DD组在实现良好临床结局方面相似(DS组为25.0%,DD组为31.3%,P = 0.293)。两组出院时的mRS评分(DS组中位数为4,DD组中位数为4,P = 0.686)、美国国立卫生研究院卒中量表(NIHSS)改善情况(DS组中位数为4,DD组中位数为5,P = 0.582)以及出院时的NIHSS评分(DS组中位数为9,DD组中位数为7,P = 0.231)相似。DS组(75.9%)和DD组(81.0%)实现成功再灌注的情况相似(P = 0.375)。与DD组相比,DS组从发病到再灌注的时间更长(中位数DS组为379分钟,DD组为286分钟,P = 0.076),从初始影像检查到再灌注的时间也更长(中位数DS组为246分钟,DD组为162分钟,P < 0.001)。
DD概念在实现相似临床结局和再通结果的同时节省时间。